Large-scale testing (Phase 3)Study completedNCT05815758
What this trial is testing
Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution
Who this might be right for
Allergic Conjunctivitis
Bausch & Lomb Incorporated 512